Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-21-002499

CEO bought 10,000 shares at $6.65 ($66,500)

From the SEC's structured data for this filing

Trades in this filing

Fried Robert N · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-13 Purchase : show line 1 in the form +10,000 $6.65 $66,500 63,001 I
Open-market purchases · 10,000 sh · avg $6.65 · $66,500
Loading xslF345X03/form4-05172021_080502.xml…